These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The need for electron paramagnetic resonance and water exchange-rate data for understanding small magnetic resonance imaging contrast agents and their macromolecular complexes. Koenig SH Invest Radiol; 1994 Jun; 29 Suppl 2():S127-30. PubMed ID: 7928207 [No Abstract] [Full Text] [Related]
27. Paramagnetic dextrans as magnetic resonance contrast agents. Meyer D; Schaefer M; Bouillot A; Beauté S; Chambon C Invest Radiol; 1991 Nov; 26 Suppl 1():S50-2; discussion S60-4. PubMed ID: 1725521 [No Abstract] [Full Text] [Related]
28. Interactions of paramagnetic contrast agents and the spin echo pulse sequence. Joseph PM Invest Radiol; 1989 Jun; 24(6):508-9. PubMed ID: 2562496 [No Abstract] [Full Text] [Related]
29. Pruritus and paresthesia after i.v. administration of Gd-DTPA. Chan K; Bosanko CM; Wang AM AJNR Am J Neuroradiol; 1989; 10(5 Suppl):S53. PubMed ID: 2505565 [No Abstract] [Full Text] [Related]
30. Parameter optimization and calibration of 19F magnetic resonance imaging at 1.5 Tesla. Gong BZ; Gill M; Washburn DB; Davenport WC; Adams D; Kwock L Magn Reson Imaging; 1991; 9(1):101-6. PubMed ID: 2056847 [TBL] [Abstract][Full Text] [Related]
31. Acute hemodynamic effects of nonionic and ionic magnetic resonance contrast media in intravenous bolus injection in rats. Masui T; Takehara Y; Aoshima R; Kaneko M Invest Radiol; 1994 Jun; 29 Suppl 2():S189-91. PubMed ID: 7928226 [No Abstract] [Full Text] [Related]
32. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT. Low RN; Francis IR AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464 [TBL] [Abstract][Full Text] [Related]
33. An experimental model to study contrast enhancement in MR imaging of the intervertebral disk. Nguyen CM; Ho KC; Yu SW; Haughton VM; Strandt JA AJNR Am J Neuroradiol; 1989; 10(4):811-4. PubMed ID: 2505508 [TBL] [Abstract][Full Text] [Related]
34. Optimal use of MR contrast agents: how much is enough? Maravilla KR AJNR Am J Neuroradiol; 1991; 12(5):881-3. PubMed ID: 1950916 [No Abstract] [Full Text] [Related]
35. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA]. Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806 [TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance imaging of rabbit brain after intracarotid injection of large multivesicular liposomes containing paramagnetic metals and DTPA. Turski P; Kalinke T; Strother L; Perman W; Scott G; Kornguth S Magn Reson Med; 1988 Jun; 7(2):184-96. PubMed ID: 3398765 [TBL] [Abstract][Full Text] [Related]
37. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine. Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025 [No Abstract] [Full Text] [Related]
38. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA]. Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470 [TBL] [Abstract][Full Text] [Related]
39. Brain distribution of MRI contrast media in rats after intracisternal injection. Allard M; Kien P; Caille JM; Bonnemain B; Simonnet G J Neuroradiol; 1987; 14(4):383-7. PubMed ID: 3131496 [No Abstract] [Full Text] [Related]
40. Quantification of liver capillary permeability using a macromolecular contrast agent for magnetic resonance imaging. Clément O; Vuillemin-Bodaghi V; Cuénod CA; Siauve N; Blustajn J; Frija G Acad Radiol; 1996 Aug; 3 Suppl 2():S342-3. PubMed ID: 8796598 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]